speb/financial-data huggingface dataset:
CME balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 121400000.00
CME balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
CME income_statement (annual, 2022-12-31) — Preferred Stock Dividends: 38900000.00
CME cash_flow (annual, 2022-12-31) — Preferred Stock Issuance: 0.00
CME income_statement (annual, 2022-12-31) — Pretax Income: 3490300000.00
CME balance_sheet (annual, 2022-12-31) — Properties: 0.00
CME cash_flow (annual, 2022-12-31) — Purchase Of Business: -413100000.00
CME cash_flow (annual, 2022-12-31) — Purchase Of Investment: -4400000.00
CME cash_flow (annual, 2022-12-31) — Purchase Of PPE: -89700000.00
CME balance_sheet (annual, 2022-12-31) — Receivables: 483200000.00
CME income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 753100000.00
CME income_statement (annual, 2022-12-31) — Reconciled Depreciation: 362600000.00
CME cash_flow (annual, 2022-12-31) — Repayment Of Debt: -756200000.00
CME balance_sheet (annual, 2022-12-31) — Restricted Cash: 135254100000.00
CME balance_sheet (annual, 2022-12-31) — Retained Earnings: 4746800000.00
CME cash_flow (annual, 2022-12-31) — Sale Of Business: 11100000.00
CME cash_flow (annual, 2022-12-31) — Sale Of Investment: 6300000.00
CME cash_flow (annual, 2022-12-31) — Sale Of PPE: 0.00
CME income_statement (annual, 2022-12-31) — Selling General And Administration: 137400000.00
CME balance_sheet (annual, 2022-12-31) — Share Issued: 358932100.00
CME cash_flow (annual, 2022-12-31) — Short Term Debt Payments: 0.00
CME cash_flow (annual, 2022-12-31) — Stock Based Compensation: 84300000.00
CME balance_sheet (annual, 2022-12-31) — Stockholders Equity: 26878700000.00
CME balance_sheet (annual, 2022-12-31) — Tangible Book Value: -4048800000.00
CME income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 503447016.02
CME income_statement (annual, 2022-12-31) — Tax Provision: 799300000.00
CME income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.23
CME balance_sheet (annual, 2022-12-31) — Total Assets: 174175700000.00
CME balance_sheet (annual, 2022-12-31) — Total Capitalization: 30301100000.00
CME balance_sheet (annual, 2022-12-31) — Total Debt: 3438400000.00
CME balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 26878700000.00
CME income_statement (annual, 2022-12-31) — Total Expenses: 2003500000.00
CME balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 147297000000.00
CME balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 35097400000.00
CME balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 9609500000.00
CME income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 3015900000.00
CME income_statement (annual, 2022-12-31) — Total Unusual Items: 2198400000.00
CME income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 2198400000.00
CME balance_sheet (annual, 2022-12-31) — Working Capital: 1390800000.00
CME income_statement (annual, 2023-12-31) — +Operating Expense: 1314600000.00
CME income_statement (annual, 2023-12-31) — +Total Revenue: 5578900000.00
CME balance_sheet (annual, 2023-12-31) — Accounts Payable: 90600000.00
CME balance_sheet (annual, 2023-12-31) — Accounts Receivable: 535600000.00
CME balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -933100000.00
CME balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 22334700000.00
CME balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -7100000.00
CME income_statement (annual, 2023-12-31) — Amortization: 226600000.00
CME cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 226600000.00
CME cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 226600000.00
CME income_statement (annual, 2023-12-31) — Amortization Of Intangibles Income Statement: 226600000.00
CME income_statement (annual, 2023-12-31) — Basic Average Shares: 359023000.00
CME income_statement (annual, 2023-12-31) — Basic EPS: 8.87
CME cash_flow (annual, 2023-12-31) — Beginning Cash Position: 137974300000.00
CME balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 130700000.00
CME cash_flow (annual, 2023-12-31) — Capital Expenditure: -76400000.00
CME balance_sheet (annual, 2023-12-31) — Capital Stock: 3600000.00
CME balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 2912000000.00
CME balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 3023700000.00
CME cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -3235500000.00
CME cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -48339300000.00
CME cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 20900000.00
CME cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 3453800000.00
CME cash_flow (annual, 2023-12-31) — Change In Account Payable: -30800000.00
CME cash_flow (annual, 2023-12-31) — Change In Income Tax Payable: -77100000.00
CME cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -545800000.00
CME cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 610000000.00
CME cash_flow (annual, 2023-12-31) — Change In Payable: -107900000.00
CME cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -107900000.00
CME cash_flow (annual, 2023-12-31) — Change In Receivables: -51500000.00
CME cash_flow (annual, 2023-12-31) — Change In Tax Payable: -77100000.00
CME cash_flow (annual, 2023-12-31) — Change In Working Capital: -95200000.00
CME cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -51500000.00
CME cash_flow (annual, 2023-12-31) — Changes In Cash: -44864600000.00
CME balance_sheet (annual, 2023-12-31) — Common Stock: 3600000.00
CME balance_sheet (annual, 2023-12-31) — Common Stock Equity: 26737900000.00
CME cash_flow (annual, 2023-12-31) — Common Stock Payments: 0.00
CME income_statement (annual, 2023-12-31) — Cost Of Revenue: 828600000.00
CME balance_sheet (annual, 2023-12-31) — Current Assets: 94890200000.00
CME balance_sheet (annual, 2023-12-31) — Current Liabilities: 93416900000.00
CME balance_sheet (annual, 2023-12-31) — Current Notes Payable: 0.00
CME cash_flow (annual, 2023-12-31) — Deferred Income Tax: -75000000.00
CME cash_flow (annual, 2023-12-31) — Deferred Tax: -75000000.00
CME cash_flow (annual, 2023-12-31) — Depreciation: 126000000.00
CME cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 352600000.00
CME income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 352600000.00
CME cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 352600000.00
CME income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 352600000.00
CME income_statement (annual, 2023-12-31) — Depreciation Income Statement: 126000000.00
CME income_statement (annual, 2023-12-31) — Diluted Average Shares: 359500000.00
CME income_statement (annual, 2023-12-31) — Diluted EPS: 8.86
CME income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 3185600000.00
CME income_statement (annual, 2023-12-31) — EBIT: 4313000000.00
CME income_statement (annual, 2023-12-31) — EBITDA: 4665600000.00
CME income_statement (annual, 2023-12-31) — Earnings From Equity Interest: 296900000.00
CME cash_flow (annual, 2023-12-31) — End Cash Position: 93109700000.00
CME cash_flow (annual, 2023-12-31) — Financing Cash Flow: -48339300000.00
CME cash_flow (annual, 2023-12-31) — Free Cash Flow: 3377400000.00
CME cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -72100000.00
CME cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: 0.00
CME cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 0.00
CME income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 5275300000.00
CME balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -55600000.00
CME income_statement (annual, 2023-12-31) — General And Administrative Expense: 144400000.00
CME balance_sheet (annual, 2023-12-31) — Goodwill: 10495300000.00
CME balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 30720800000.00
CME balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 542700000.00
CME balance_sheet (annual, 2023-12-31) — Gross PPE: 1342600000.00
CME income_statement (annual, 2023-12-31) — Gross Profit: 4750300000.00
CME cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 1071700000.00
CME income_statement (annual, 2023-12-31) — Interest Expense: 159400000.00
CME income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 159400000.00
CME cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 129900000.00
CME balance_sheet (annual, 2023-12-31) — Invested Capital: 30163300000.00
CME cash_flow (annual, 2023-12-31) — Investing Cash Flow: 20900000.00
CME cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
CME cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
CME balance_sheet (annual, 2023-12-31) — Leases: 143700000.00
CME balance_sheet (annual, 2023-12-31) — Long Term Debt: 3425400000.00
CME balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 3425400000.00
CME cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
CME cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -16400000.00
CME balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 1068200000.00
CME income_statement (annual, 2023-12-31) — Minority Interests: 0.00
CME cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 95500000.00
CME cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
CME balance_sheet (annual, 2023-12-31) — Net Debt: 513400000.00
CME income_statement (annual, 2023-12-31) — Net Income: 3226200000.00
CME income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 3185600000.00
CME income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 3226200000.00
CME income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 3226200000.00
CME income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 3226200000.00
CME cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 3226200000.00
CME income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 3226200000.00
CME income_statement (annual, 2023-12-31) — Net Interest Income: -159400000.00
CME cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 1800000.00
CME cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -16400000.00
CME cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -16400000.00
CME income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -159400000.00
CME cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -45087400000.00
CME balance_sheet (annual, 2023-12-31) — Net PPE: 409500000.00
CME cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -76400000.00
CME cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: 0.00
CME balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -3982900000.00
CME balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 5327700000.00
CME balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 5327700000.00
CME income_statement (annual, 2023-12-31) — Normalized EBITDA: -609700000.00
CME income_statement (annual, 2023-12-31) — Normalized Income: -871251093.03
CME cash_flow (annual, 2023-12-31) — Operating Cash Flow: 3453800000.00
CME cash_flow (annual, 2023-12-31) — Operating Gains Losses: -72100000.00
CME income_statement (annual, 2023-12-31) — Operating Income: 3435700000.00
CME income_statement (annual, 2023-12-31) — Operating Revenue: 5252200000.00
CME balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 359234138.00
CME balance_sheet (annual, 2023-12-31) — Other Current Assets: 1133200000.00
CME balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 93326300000.00
CME balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -55600000.00
CME income_statement (annual, 2023-12-31) — Other Gand A: 144400000.00
CME income_statement (annual, 2023-12-31) — Other Income Expense: 877300000.00
CME balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 20225500000.00
CME cash_flow (annual, 2023-12-31) — Other Non Cash Items: 34400000.00
CME balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 3685600000.00
CME balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 798200000.00
CME income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -4694900000.00
CME income_statement (annual, 2023-12-31) — Other Operating Expenses: 817600000.00
CME balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 111700000.00
CME income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: -3600000.00
CME balance_sheet (annual, 2023-12-31) — Payables: 90600000.00
CME balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 90600000.00
CME balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
CME income_statement (annual, 2023-12-31) — Preferred Stock Dividends: 44200000.00
CME cash_flow (annual, 2023-12-31) — Preferred Stock Issuance: 0.00
CME income_statement (annual, 2023-12-31) — Pretax Income: 4153600000.00
CME balance_sheet (annual, 2023-12-31) — Properties: 0.00
CME cash_flow (annual, 2023-12-31) — Purchase Of Business: -2400000.00
CME cash_flow (annual, 2023-12-31) — Purchase Of Investment: -4100000.00
CME cash_flow (annual, 2023-12-31) — Purchase Of PPE: -76400000.00
CME balance_sheet (annual, 2023-12-31) — Receivables: 535600000.00
CME income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 828600000.00
CME income_statement (annual, 2023-12-31) — Reconciled Depreciation: 352600000.00
CME cash_flow (annual, 2023-12-31) — Repayment Of Debt: -16400000.00
CME cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: 0.00
CME balance_sheet (annual, 2023-12-31) — Restricted Cash: 90197700000.00
CME balance_sheet (annual, 2023-12-31) — Retained Earnings: 4455200000.00
CME cash_flow (annual, 2023-12-31) — Sale Of Business: 97900000.00
CME cash_flow (annual, 2023-12-31) — Sale Of Investment: 5900000.00
CME cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
CME income_statement (annual, 2023-12-31) — Selling General And Administration: 144400000.00
CME balance_sheet (annual, 2023-12-31) — Share Issued: 359234138.00
CME cash_flow (annual, 2023-12-31) — Stock Based Compensation: 82900000.00
CME balance_sheet (annual, 2023-12-31) — Stockholders Equity: 26737900000.00
CME balance_sheet (annual, 2023-12-31) — Tangible Book Value: -3982900000.00
CME income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 1177848906.97
CME income_statement (annual, 2023-12-31) — Tax Provision: 927400000.00
CME income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.22
CME balance_sheet (annual, 2023-12-31) — Total Assets: 129706100000.00
CME balance_sheet (annual, 2023-12-31) — Total Capitalization: 30163300000.00
CME balance_sheet (annual, 2023-12-31) — Total Debt: 3425400000.00
CME balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 26737900000.00
CME income_statement (annual, 2023-12-31) — Total Expenses: 2143200000.00
CME balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 102968200000.00
CME balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 34815900000.00
CME balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 9551300000.00
CME income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 3435700000.00
CME income_statement (annual, 2023-12-31) — Total Unusual Items: 5275300000.00
CME income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 5275300000.00
CME balance_sheet (annual, 2023-12-31) — Working Capital: 1473300000.00
CME balance_sheet (quarterly, 2024-09-30) — Current Debt: 749700000.00
CME balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 749700000.00
CME balance_sheet (quarterly, 2024-09-30) — Other Current Borrowings: 749700000.00
CME cash_flow (quarterly, 2024-09-30) — Other Non Cash Items: 12300000.00
CME balance_sheet (quarterly, 2024-09-30) — Properties: 1398600000.00
CME income_statement (annual, 2024-12-31) — +Operating Expense: 1348300000.00
CME income_statement (annual, 2024-12-31) — +Total Revenue: 6130100000.00
CME balance_sheet (annual, 2024-12-31) — Accounts Payable: 79900000.00
CME balance_sheet (annual, 2024-12-31) — Accounts Receivable: 573100000.00
CME balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -1024300000.00
CME balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -1024300000.00
CME balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 22403000000.00
CME balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -9000000.00
CME income_statement (annual, 2024-12-31) — Amortization: 221700000.00
CME cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 221700000.00
CME cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 221700000.00
CME income_statement (annual, 2024-12-31) — Amortization Of Intangibles Income Statement: 221700000.00
CME income_statement (annual, 2024-12-31) — Basic Average Shares: 359389000.00
CME income_statement (annual, 2024-12-31) — Basic EPS: 9.69
CME cash_flow (annual, 2024-12-31) — Beginning Cash Position: 93109700000.00
CME balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 130700000.00
CME balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 130700000.00
CME cash_flow (annual, 2024-12-31) — Capital Expenditure: -94000000.00
CME balance_sheet (annual, 2024-12-31) — Capital Stock: 3600000.00
CME balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 2892400000.00
CME balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 3005600000.00
CME cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -3584200000.00
CME cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 5076500000.00
CME cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -82600000.00
CME cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 3690500000.00
CME cash_flow (annual, 2024-12-31) — Change In Account Payable: -10700000.00
CME cash_flow (annual, 2024-12-31) — Change In Income Tax Payable: -117400000.00
CME cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 740200000.00
CME cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -761300000.00
CME cash_flow (annual, 2024-12-31) — Change In Payable: -128100000.00
CME cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -128100000.00
CME cash_flow (annual, 2024-12-31) — Change In Receivables: -39400000.00
CME cash_flow (annual, 2024-12-31) — Change In Tax Payable: -117400000.00
CME cash_flow (annual, 2024-12-31) — Change In Working Capital: -188600000.00
CME cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -39400000.00
CME cash_flow (annual, 2024-12-31) — Changes In Cash: 8684400000.00
CME balance_sheet (annual, 2024-12-31) — Common Stock: 3600000.00
CME balance_sheet (annual, 2024-12-31) — Common Stock Equity: 26486900000.00
CME cash_flow (annual, 2024-12-31) — Common Stock Payments: 0.00
CME income_statement (annual, 2024-12-31) — Cost Of Revenue: 850300000.00
CME balance_sheet (annual, 2024-12-31) — Current Assets: 103033500000.00
CME balance_sheet (annual, 2024-12-31) — Current Debt: 749800000.00
CME balance_sheet (quarterly, 2024-12-31) — Current Debt: 749800000.00
CME balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 749800000.00
CME balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 749800000.00
CME balance_sheet (annual, 2024-12-31) — Current Liabilities: 102313900000.00
CME cash_flow (annual, 2024-12-31) — Deferred Income Tax: -66400000.00
CME cash_flow (annual, 2024-12-31) — Deferred Tax: -66400000.00
CME cash_flow (annual, 2024-12-31) — Depreciation: 115100000.00
CME cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 336800000.00
CME income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 336800000.00
CME cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 336800000.00
CME income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 336800000.00
CME income_statement (annual, 2024-12-31) — Depreciation Income Statement: 115100000.00
CME income_statement (annual, 2024-12-31) — Diluted Average Shares: 359944000.00
CME income_statement (annual, 2024-12-31) — Diluted EPS: 9.67
CME income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 3481500000.00
CME income_statement (annual, 2024-12-31) — EBIT: 4702300000.00
CME income_statement (annual, 2024-12-31) — EBITDA: 5039100000.00
CME income_statement (annual, 2024-12-31) — Earnings From Equity Interest: 350900000.00
CME cash_flow (annual, 2024-12-31) — End Cash Position: 101794100000.00
CME cash_flow (annual, 2024-12-31) — Financing Cash Flow: 5076500000.00
CME cash_flow (annual, 2024-12-31) — Free Cash Flow: 3596500000.00
CME cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -3600000.00
CME income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 4079100000.00
CME balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -105500000.00
CME income_statement (annual, 2024-12-31) — General And Administrative Expense: 132700000.00
CME balance_sheet (annual, 2024-12-31) — Goodwill: 10486900000.00
CME balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 30483800000.00
CME balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 582100000.00
CME balance_sheet (annual, 2024-12-31) — Gross PPE: 1410500000.00
CME income_statement (annual, 2024-12-31) — Gross Profit: 5279800000.00
CME cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 1196500000.00
CME income_statement (annual, 2024-12-31) — Interest Expense: 160900000.00
CME income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 160900000.00
CME cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 129900000.00
CME balance_sheet (annual, 2024-12-31) — Invested Capital: 29914900000.00
CME cash_flow (annual, 2024-12-31) — Investing Cash Flow: -82600000.00
CME cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
CME balance_sheet (annual, 2024-12-31) — Leases: 147100000.00
CME balance_sheet (quarterly, 2024-12-31) — Leases: 147100000.00
CME balance_sheet (annual, 2024-12-31) — Long Term Debt: 2678200000.00
CME balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 2678200000.00
CME cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
CME cash_flow (annual, 2024-12-31) — Long Term Debt Payments: 0.00
CME balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 1132700000.00
CME balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 1132700000.00
CME cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 9900000.00
CME cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
CME balance_sheet (annual, 2024-12-31) — Net Debt: 535600000.00
CME balance_sheet (quarterly, 2024-12-31) — Net Debt: 535600000.00
CME income_statement (annual, 2024-12-31) — Net Income: 3525800000.00
CME income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 3481500000.00
CME income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 3525800000.00
CME income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 3525800000.00
CME income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 3525800000.00
CME cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 3525800000.00
CME income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 3525800000.00
CME income_statement (annual, 2024-12-31) — Net Interest Income: -160900000.00
CME cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 1500000.00
CME cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
CME cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 0.00
CME income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -160900000.00
CME cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 8660700000.00
CME balance_sheet (annual, 2024-12-31) — Net PPE: 386200000.00
CME cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -94000000.00
CME balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -3996900000.00
CME balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 5246800000.00
CME balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 5246800000.00
CME income_statement (annual, 2024-12-31) — Normalized EBITDA: 960000000.00
CME income_statement (annual, 2024-12-31) — Normalized Income: 360418400.00
CME cash_flow (annual, 2024-12-31) — Operating Cash Flow: 3690500000.00
CME cash_flow (annual, 2024-12-31) — Operating Gains Losses: -3600000.00
CME income_statement (annual, 2024-12-31) — Operating Income: 3931500000.00
CME income_statement (annual, 2024-12-31) — Operating Revenue: 5698400000.00
CME balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 359605138.00
CME balance_sheet (annual, 2024-12-31) — Other Current Assets: 553100000.00
CME balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 749800000.00
CME balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 749800000.00
CME balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 101484200000.00
CME balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -105500000.00
CME income_statement (annual, 2024-12-31) — Other Gand A: 132700000.00
CME income_statement (annual, 2024-12-31) — Other Income Expense: 770800000.00
CME balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 19996900000.00
CME cash_flow (annual, 2024-12-31) — Other Non Cash Items: -3000000.00
CME cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: 2300000.00
CME balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 3543500000.00
CME balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 721200000.00
CME income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -3659200000.00
CME income_statement (annual, 2024-12-31) — Other Operating Expenses: 878800000.00
CME balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 113200000.00
CME income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: -3400000.00
CME balance_sheet (annual, 2024-12-31) — Payables: 79900000.00
CME balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 79900000.00
CME balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
CME income_statement (annual, 2024-12-31) — Preferred Stock Dividends: 47700000.00
CME income_statement (annual, 2024-12-31) — Pretax Income: 4541400000.00
CME balance_sheet (annual, 2024-12-31) — Properties: 0.00
CME balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
CME cash_flow (annual, 2024-12-31) — Purchase Of Business: -3600000.00
CME cash_flow (annual, 2024-12-31) — Purchase Of Investment: -4500000.00
CME cash_flow (annual, 2024-12-31) — Purchase Of PPE: -94000000.00
CME balance_sheet (annual, 2024-12-31) — Receivables: 573100000.00
CME income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 850300000.00
CME income_statement (annual, 2024-12-31) — Reconciled Depreciation: 336800000.00
CME cash_flow (annual, 2024-12-31) — Repayment Of Debt: 0.00
CME cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
CME balance_sheet (annual, 2024-12-31) — Restricted Cash: 98901700000.00
CME balance_sheet (annual, 2024-12-31) — Retained Earnings: 4185800000.00
CME cash_flow (annual, 2024-12-31) — Sale Of Business: 13500000.00
CME cash_flow (annual, 2024-12-31) — Sale Of Investment: 6000000.00
CME income_statement (annual, 2024-12-31) — Selling General And Administration: 132700000.00
CME balance_sheet (annual, 2024-12-31) — Share Issued: 359605138.00
CME cash_flow (annual, 2024-12-31) — Stock Based Compensation: 89500000.00
CME balance_sheet (annual, 2024-12-31) — Stockholders Equity: 26486900000.00
CME balance_sheet (annual, 2024-12-31) — Tangible Book Value: -3996900000.00
CME income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 913718400.00
CME income_statement (annual, 2024-12-31) — Tax Provision: 1015600000.00
CME income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.22
CME balance_sheet (annual, 2024-12-31) — Total Assets: 137447000000.00
CME balance_sheet (annual, 2024-12-31) — Total Capitalization: 29165100000.00
CME balance_sheet (annual, 2024-12-31) — Total Debt: 3428000000.00
CME balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 26486900000.00
CME income_statement (annual, 2024-12-31) — Total Expenses: 2198600000.00
CME balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 110960100000.00
CME balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 34413500000.00
CME balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 8646200000.00
CME income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 3931500000.00
CME income_statement (annual, 2024-12-31) — Total Unusual Items: 4079100000.00
CME income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 4079100000.00
CME balance_sheet (annual, 2024-12-31) — Working Capital: 719600000.00
CME income_statement (quarterly, 2025-03-31) — +Operating Expense: 327600000.00
CME income_statement (quarterly, 2025-03-31) — +Total Revenue: 1642300000.00
CME balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 100200000.00
CME balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 770200000.00
CME balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 22416000000.00
CME balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -8700000.00
CME income_statement (quarterly, 2025-03-31) — Amortization: 55200000.00
CME cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 55200000.00
CME cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 55200000.00
CME income_statement (quarterly, 2025-03-31) — Amortization Of Intangibles Income Statement: 55200000.00
CME income_statement (quarterly, 2025-03-31) — Average Dilution Earnings: 0.00
CME income_statement (quarterly, 2025-03-31) — Basic Average Shares: 359613000.00
CME income_statement (quarterly, 2025-03-31) — Basic EPS: 2.63
CME cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 101794100000.00
CME cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -14200000.00
CME balance_sheet (quarterly, 2025-03-31) — Capital Stock: 3600000.00
CME balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1405300000.00
CME balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1519200000.00
CME cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -2567400000.00
CME cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 19211400000.00
CME cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -16000000.00
CME cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 1116600000.00
CME cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 20300000.00
CME cash_flow (quarterly, 2025-03-31) — Change In Income Tax Payable: 280900000.00
CME cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 16500000.00
CME cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -59900000.00
CME cash_flow (quarterly, 2025-03-31) — Change In Payable: 301200000.00
CME cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 301200000.00
CME cash_flow (quarterly, 2025-03-31) — Change In Receivables: -196800000.00
CME cash_flow (quarterly, 2025-03-31) — Change In Tax Payable: 280900000.00
CME cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 61000000.00
CME cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -196800000.00
CME cash_flow (quarterly, 2025-03-31) — Changes In Cash: 20312000000.00
CME balance_sheet (quarterly, 2025-03-31) — Common Stock: 3600000.00
CME cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -2567400000.00
CME balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 27030700000.00
CME cash_flow (quarterly, 2025-03-31) — Common Stock Payments: 0.00
CME income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 206700000.00
CME balance_sheet (quarterly, 2025-03-31) — Current Assets: 123445400000.00
CME balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 121420200000.00
CME cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -7400000.00
CME cash_flow (quarterly, 2025-03-31) — Deferred Tax: -7400000.00
CME cash_flow (quarterly, 2025-03-31) — Depreciation: 27300000.00
CME cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 82500000.00
CME income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 82500000.00
CME cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 82500000.00
CME income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 82500000.00
CME income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 27300000.00
CME income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 360227000.00
CME income_statement (quarterly, 2025-03-31) — Diluted EPS: 2.62
CME income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 944200000.00
CME income_statement (quarterly, 2025-03-31) — EBIT: 1286500000.00
CME income_statement (quarterly, 2025-03-31) — EBITDA: 1369000000.00
CME income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: 88200000.00
CME cash_flow (quarterly, 2025-03-31) — End Cash Position: 122106100000.00
CME cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 19211400000.00
CME cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 1102400000.00
CME cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -2600000.00
CME income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 892700000.00
CME balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -74800000.00
CME income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 28500000.00
CME balance_sheet (quarterly, 2025-03-31) — Goodwill: 10499500000.00
CME balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 30448000000.00
CME balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 778900000.00
CME balance_sheet (quarterly, 2025-03-31) — Gross PPE: 371200000.00
CME income_statement (quarterly, 2025-03-31) — Gross Profit: 1435600000.00
CME cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 12700000.00
CME income_statement (quarterly, 2025-03-31) — Interest Expense: 41700000.00
CME income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 41700000.00
CME cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 41100000.00
CME balance_sheet (quarterly, 2025-03-31) — Invested Capital: 30450100000.00
CME cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -16000000.00
CME cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 742300000.00
CME balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 3419400000.00
CME balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 3419400000.00
CME cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 742300000.00
CME cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -750000000.00
CME cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -2400000.00
CME cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
CME balance_sheet (quarterly, 2025-03-31) — Net Debt: 2014100000.00
CME income_statement (quarterly, 2025-03-31) — Net Income: 956200000.00
CME income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 944200000.00
CME income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 956200000.00
CME income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 956200000.00
CME income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 956200000.00
CME cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 956200000.00
CME income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 956200000.00
CME income_statement (quarterly, 2025-03-31) — Net Interest Income: -41700000.00
CME cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 600000.00
CME cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -7700000.00
CME cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -7700000.00
CME income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -41700000.00
CME cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: 21786500000.00
CME balance_sheet (quarterly, 2025-03-31) — Net PPE: 371200000.00
CME cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -14200000.00
CME balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -3417300000.00
CME balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 5240100000.00
CME balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 5240100000.00
CME income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 476300000.00
CME income_statement (quarterly, 2025-03-31) — Normalized Income: 270606400.00
CME cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 1116600000.00
CME cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -2600000.00
CME income_statement (quarterly, 2025-03-31) — Operating Income: 1108000000.00
CME income_statement (quarterly, 2025-03-31) — Operating Revenue: 1531800000.00
CME balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 359649138.00
CME balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 455200000.00
CME balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 121320000000.00
CME balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -74800000.00
CME income_statement (quarterly, 2025-03-31) — Other Gand A: 28500000.00
CME income_statement (quarterly, 2025-03-31) — Other Income Expense: 178500000.00
CME balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 19948500000.00
CME cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 5700000.00
CME balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 3567000000.00
CME balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 721200000.00
CME income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -802400000.00
CME income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 216600000.00
CME balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 113900000.00
CME income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 6300000.00
CME balance_sheet (quarterly, 2025-03-31) — Payables: 100200000.00
CME balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 100200000.00
CME balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
CME income_statement (quarterly, 2025-03-31) — Preferred Stock Dividends: 5700000.00
CME income_statement (quarterly, 2025-03-31) — Pretax Income: 1244800000.00
CME balance_sheet (quarterly, 2025-03-31) — Properties: 371200000.00
CME cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -2400000.00
CME cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -3000000.00
CME cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -14200000.00
CME balance_sheet (quarterly, 2025-03-31) — Receivables: 770200000.00
CME income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 206700000.00
CME income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 82500000.00
CME cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -750000000.00
CME cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: 0.00
CME balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 120700800000.00
CME balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 4685900000.00
CME cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 3600000.00
CME income_statement (quarterly, 2025-03-31) — Selling General And Administration: 28500000.00
CME balance_sheet (quarterly, 2025-03-31) — Share Issued: 359649138.00
CME cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 21200000.00
CME balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 27030700000.00
CME balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -3417300000.00
CME income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 207106400.00
CME income_statement (quarterly, 2025-03-31) — Tax Provision: 288600000.00
CME income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.23
CME balance_sheet (quarterly, 2025-03-31) — Total Assets: 157831600000.00
CME balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 30450100000.00
CME balance_sheet (quarterly, 2025-03-31) — Total Debt: 3419400000.00
CME balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 27030700000.00
CME income_statement (quarterly, 2025-03-31) — Total Expenses: 534300000.00
CME balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 130800900000.00
CME balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 34386200000.00
CME balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 9380700000.00
CME income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 1108000000.00
CME income_statement (quarterly, 2025-03-31) — Total Unusual Items: 892700000.00
CME income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 892700000.00
CME balance_sheet (quarterly, 2025-03-31) — Working Capital: 2025200000.00
CME income_statement (quarterly, 2025-06-30) — +Operating Expense: 341100000.00
CME income_statement (quarterly, 2025-06-30) — +Total Revenue: 1692000000.00
CME balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 92300000.00
CME balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 667600000.00
CME balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -960800000.00
CME balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 22435100000.00
CME balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -9900000.00
CME income_statement (quarterly, 2025-06-30) — Amortization: 56100000.00
CME cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 56100000.00
CME cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 56100000.00
CME income_statement (quarterly, 2025-06-30) — Amortization Of Intangibles Income Statement: 56100000.00
CME income_statement (quarterly, 2025-06-30) — Basic Average Shares: 359658000.00
CME income_statement (quarterly, 2025-06-30) — Basic EPS: 2.81
CME cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 122106100000.00
CME cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -18400000.00
CME balance_sheet (quarterly, 2025-06-30) — Capital Stock: 3600000.00
CME balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 1981300000.00
CME balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 2098900000.00
CME cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -455300000.00
CME cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 20999200000.00
CME cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -18000000.00
CME cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 1058500000.00
CME cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -7800000.00
CME cash_flow (quarterly, 2025-06-30) — Change In Income Tax Payable: -252600000.00
CME cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -11300000.00
CME cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 118600000.00
CME cash_flow (quarterly, 2025-06-30) — Change In Payable: -260400000.00
CME cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -260400000.00
CME cash_flow (quarterly, 2025-06-30) — Change In Receivables: 101400000.00
CME cash_flow (quarterly, 2025-06-30) — Change In Tax Payable: -252600000.00
CME cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -51700000.00
CME cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 101400000.00
CME cash_flow (quarterly, 2025-06-30) — Changes In Cash: 22039700000.00
CME balance_sheet (quarterly, 2025-06-30) — Common Stock: 3600000.00
CME balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 27739000000.00
CME cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -8200000.00
CME income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 221600000.00
CME balance_sheet (quarterly, 2025-06-30) — Current Assets: 145450100000.00
CME balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 142794800000.00
CME cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -13300000.00
CME cash_flow (quarterly, 2025-06-30) — Deferred Tax: -13300000.00
CME cash_flow (quarterly, 2025-06-30) — Depreciation: 27300000.00
CME cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 83400000.00
CME income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 83400000.00
CME cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 83400000.00
CME income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 83400000.00
CME income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 27300000.00
CME income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 360355000.00
CME income_statement (quarterly, 2025-06-30) — Diluted EPS: 2.81
CME income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 1012200000.00
CME income_statement (quarterly, 2025-06-30) — EBIT: 1374300000.00
CME income_statement (quarterly, 2025-06-30) — EBITDA: 1457700000.00
CME income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: 99000000.00
CME cash_flow (quarterly, 2025-06-30) — End Cash Position: 144145800000.00
CME cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 20999200000.00
CME cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 1040100000.00
CME cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 0.00
CME income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 1518400000.00
CME balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 45400000.00
CME income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 37400000.00
CME balance_sheet (quarterly, 2025-06-30) — Goodwill: 10523900000.00
CME balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 30427700000.00
CME balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 677500000.00
CME balance_sheet (quarterly, 2025-06-30) — Gross PPE: 1323700000.00
CME income_statement (quarterly, 2025-06-30) — Gross Profit: 1470400000.00
CME cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 566900000.00
CME income_statement (quarterly, 2025-06-30) — Interest Expense: 44000000.00
CME income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 44000000.00
CME cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 23900000.00
CME balance_sheet (quarterly, 2025-06-30) — Invested Capital: 31159400000.00
CME cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -18000000.00
CME cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
CME balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 3420400000.00
CME balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 3420400000.00
CME cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 0.00